Medtronic launches DCB clinical trial for below-the-knee peripheral artery disease

Medtronic (NYSE:MDT) said today that it launched a clinical trial to evaluate the use of its In.Pact paclitaxel-coated percutaneous transluminal angioplasty balloon catheter in patients with below-the-knee peripheral arterial disease.
The company treated its 1st patient in the In.Pact BTK study, performing the procedure on a patient with critical limb ischemia.
Get the full story at our sister site, Drug Delivery Business News.
The post Medtronic launches DCB clinical trial for below-the-knee peripheral artery disease appeared first on MassDevice.

Source: Mass Device - March 9, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Vascular Medtronic Source Type: news